Mia's Feed
Medical News & Research

Innovative Lung-on-a-Chip with Immune Function Mimics a Living Organ

Innovative Lung-on-a-Chip with Immune Function Mimics a Living Organ

Share this article

A pioneering lung-on-a-chip with an active immune system offers new insights into lung disease, infection response, and personalized therapies, transforming preclinical research and reducing animal testing.

2 min read

Researchers at Georgia Tech and Vanderbilt University have developed a groundbreaking lung-on-a-chip that integrates a functional immune system, marking a significant advancement in biomedical engineering. This miniature model of the human lung, constructed on a flexible polymer chip, simulates the organ’s natural behavior, including expansion, blood circulation, and immune responses. Unlike previous models, this innovative platform enables scientists to observe immune cell movement and response within lung tissue, providing deeper insights into how the lungs combat infections and inflammatory diseases.

The development was led by Ankur Singh, director of Georgia Tech's Center for Immunoengineering, who described witnessing immune cells actively migrating through the chip as a transformative moment. Alongside Krishnendu Roy and colleagues, Singh’s team faced the challenge of maintaining viable immune cells within the chip, a hurdle they successfully overcame, resulting in a model where immune responses to pathogens like influenza could be closely studied.

This model not only responds accurately to infections but also offers a more human-relevant alternative to traditional animal testing, which often fails to fully replicate human lung responses. Singh emphasized the importance of this technology for understanding severe viral infections and developing effective treatments. The platform holds promise for studying other lung diseases such as asthma, cystic fibrosis, and lung cancer, and aims toward personalized medicine by creating patient-specific chips.

This innovation could revolutionize the way respiratory diseases are researched, allowing for better prediction of treatment efficacy and reducing reliance on animal models. It exemplifies a significant step toward more accurate, human-relevant preclinical testing and could ultimately lead to improved therapies and outcomes for millions suffering from lung ailments.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Breakthrough Study Highlights Promising Peptide Therapy Against Aggressive Brain Cancer

Virginia Tech scientists have developed a promising peptide therapy targeting glioblastoma stem cells that could reduce tumor recurrence and improve treatment outcomes.

Post-Surgery Radiation Therapy Significantly Lowers Pelvic Recurrence in Advanced Bladder Cancer Patients

A groundbreaking Phase III trial shows that radiation therapy after bladder removal significantly reduces pelvic relapse in advanced bladder cancer patients, with minimal side effects. This new approach could become a standard part of high-risk bladder cancer treatment to improve outcomes.

Enhancing Brain Immune Cell Enzyme Could Offer New Treatment Path for Alzheimer's

Scientists at Cedars-Sinai have found that boosting ACE enzyme levels in brain immune cells may protect against and reverse Alzheimer's disease effects, opening new avenues for therapy.